Quintiles has launched Kun Tuo, a local CRO built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China. The new unit will focus on developing customized solutions to help local and global biopharma companies achieve successful registration of new medicines in China. Quintile has operated in China since 1997, and has more than 300 staff to cover all population centers and study sites in the country. Kun Tuo will provide a ...